Literature DB >> 25979641

Remarkable Pathologic Change in Advanced Prostate Cancer Patient Using Dendritic Cell-Cytokine-Induced Killer Combined Therapy: A Case Report.

Peng Xu1, Peng Ju Li1, Kai Guo1, Yanjie He2, Chao Ma3, Zhong Jin1, Yiming Zhang1, Yukun Ge1, Abai Xu1, Shaobo Zheng1, Yuhua Li2, Chunxiao Liu1, Peng Huang4.   

Abstract

Entities:  

Keywords:  Androgen deprivation therapy; Chemoradiotherapy; Immunotherapy; Prostrate; Synergistic

Mesh：

Substances：

Year:  2015        PMID： 25979641     DOI： 10.1016/j.clgc.2015.04.006

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN： 1558-7673            Impact factor:   2.872


× No keyword cloud information.
  2 in total

1.  Real-time monitoring of tumor progression and drug responses in a preclinical mouse model of prostate cancer.

Authors:  Peng Xu; Naijin Xu; Kai Guo; Abai Xu; Fumiaki Takenaka; Eiji Matsuura; Chunxiao Liu; Hiromi Kumon; Peng Huang
Journal:  Oncotarget       Date:  2016-05-31

2.  Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results.

Authors:  Phuc Van Pham; Hanh Thi Le; Binh Thanh Vu; Viet Quoc Pham; Phong Minh Le; Nhan Lu-Chinh Phan; Ngu Van Trinh; Huyen Thi-Lam Nguyen; Sinh Truong Nguyen; Toan Linh Nguyen; Ngoc Kim Phan
Journal:  Onco Targets Ther       Date:  2016-07-21       Impact factor: 4.147
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.